Guías NICE, abril, mayo y junio de 2015

Enlace a todas las guías por especialidad

Abril

Reference Guidance Programme Topic STA In development  Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] Technology appraisal guidance Systemic lupus erythematosus Mayo Reference Guidance Programme Topic NG9 Bronchiolitis in children Guideline Respiratory infections NG10 Violence and aggression: short-term management in mental health, health and community settings Guideline Patient and service user care NG11 Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges Guideline Patient and service user care

Junio

Reference Guidance Programme Topic NG13 Workplace policy and management practices to improve the health and wellbeing of employees  Guideline Workplaces  NG12 Suspected cancer: recognition and referral  Guideline Cervical cancer  SFCQS88 NICE support for commissioning for personality disorders: borderline and antisocial  Support for commissioning Personality disorders  TA339 Omalizumab for previously treated chronic spontaneous urticaria  Technology appraisal guidance Skin conditions: general and other  TA342 Vedolizumab for treating moderately to severely active ulcerative colitis  Technology appraisal guidance Inflammatory bowel disease  TA341 Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism  Technology appraisal guidance Embolism and thrombosis  TA340 Ustekinumab for treating active psoriatic arthritis (rapid review of technology appraisal guidance 313)  Technology appraisal guidance Arthritis  IPG519 Insertion of an epiretinal prosthesis for retinitis pigmentosa  Interventional procedure guidance Eye conditions: general and other  IPG521 Suture fixation of acute disruption of the distal tibiofibular syndesmosis  Interventional procedure guidance Musculoskeletal conditions: general and other  IPG523 Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis  Interventional procedure guidance Embolism and thrombosis  NG8 Anaemia management in people with chronic kidney disease  Guideline Blood conditions  DG17 Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index  Diagnostics guidance Prostate cancer  TA343 Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding  IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis  IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids  QS90 Urinary tract infections in adults  Quality standards Urinary tract infection  QS91 Prostate cancer  Quality standards Prostate cancer  QS87 Osteoarthritis  Quality standards Arthritis  QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders  QS89 Pressure ulcers  Quality standards Pressure ulcers  IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions  IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins  IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches  STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis  TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding  IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis  IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids  QS90 Urinary tract infections in adults  Quality standards Urinary tract infection  QS91 Prostate cancer  Quality standards Prostate cancer  QS87 Osteoarthritis  Quality standards Arthritis  QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders  QS89 Pressure ulcers  Quality standards Pressure ulcers  IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions  IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins  IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches  STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis